諾瓦瓦克斯醫藥 NVAX 深 滬
等待開盤 08-21 09:30:00 美东时间
8.42
-0.370
-4.21%
華盛通- 最 高8.66
- 今 開8.50
- 成交量 597.31万股
- 最 低 8.02
- 昨 收 8.79
- 總市值 13.89亿
- 52周最高 11.97
- 市盈率 靜 3.31
- 換手率 3.62%
- 52周最低 6.20
- 委 比 -49.09%
- 總股本 1.65亿
- 歷史最高 331.68
- 量 比 1.41
- 振 幅 7.28%
- 歷史最低 3.5324
- 每 手 1
- 風險率 1.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Novavax Stock Moves Higher Wednesday: What's Driving the Action?
Shares of Novavax Inc (NASDAQ:NVAX) are trading higher Wednesday. The move comes as a major clinical victory in the oncology space generated widespread momentum across vaccine developers and the broader biotechnology sector. Novavax shares are climbing with conviction. Why are NVAX shares rallying? ...
08-20 00:33
SK海力士涨近5%，Moderna涨超83%！美股三大指数集体高开
8月19日，美股三大指数集体高开，道琼斯指数涨0.37%，标普500指数涨0.41%，纳斯达克综合指数涨0.36%。Moderna（MRNA.US）涨超83%...
08-19 21:33
U.K. regulator reaffirms safety of childhood vaccination
Days after President Donald Trump ordered major changes to the U.S. childhood immunization schedule, the U.K. drug regulator on Wednesday reaffirmed the safety of pediatric vaccination, noting it rema...
08-12 21:13
财报速睇 | 诺瓦瓦克斯医药 2026财年Q2营收0.57亿美元，同比下降76.2%；归母净利润亏损0.53亿美元，由盈转亏
华盛资讯8月6日讯，诺瓦瓦克斯医药公布2026财年Q2业绩，公司Q2营收0.57亿美元，同比下降76.2%，归母净利润亏损0.53亿美元，由盈转亏。
08-06 21:05
财报速睇 | 诺瓦瓦克斯医药 2026财年Q2营收0.57亿美元，同比下降76.3%；归母净利润亏损0.53亿美元，由盈转亏
华盛资讯8月6日讯，诺瓦瓦克斯医药公布2026财年Q2业绩，公司Q2营收0.57亿美元，同比下降76.3%，归母净利润亏损0.53亿美元，由盈转亏。
08-06 20:05
Novavax Raises FY2026 Sales Guidance from $230.000M-$270.000M to $235.000M-$275.000M vs $389.234M Est
Novavax (NASDAQ:NVAX) raises FY2026 sales outlook from $230.000 million-$270.000 million to $235.000 million-$275.000 million vs $389.234 million estimate.
08-06 20:02
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in June 2026
Short interest data from late June 2026 highlights deeply divided investor sentiment across the healthcare sector. Strong bearish bets remain heavily concentrated in speculative biotech plays like Rec...
07-01 22:20
RFK Jr. ends Emergency Use Authorizations for COVID-19 drugs
HHS Secretary Robert F. Kennedy Jr. has terminated Emergency Use Authorizations for drugs and medical devices to treat COVID-19. The EUAs for drugs and biologics will end in 12 months and in 180 days ...
07-01 02:30
Novavax faces renewed attack by Shah Capital after AGM
Shah Capital, the largest shareholder of Novavax (NVAX), criticized the company’s leadership on Wednesday, even after the COVID-19 vaccine developer managed to get shareholder backing for all resoluti...
06-24 20:43
投资者密集搜索诺瓦瓦克斯医药（NVAX）：以下是你需要了解的信息
诺瓦瓦克斯（Novavax，股票代码NVAX）近期进入Zacks网站最高搜索量股票榜单，相关基本面因素可作为判断其短期走势的核心依据。 过去一个月，诺瓦瓦克斯股...
06-23 22:06
